<Anchor>
Children aged 5-11 can also receive the vaccine from the end of this month.
The third vaccination has also been started for adolescents between the ages of 12 and 17.
Reporter Kim Deok-hyun reports.
<Reporter>
About 3.07 million people aged 5-11 are licensed for vaccination.
Those born in 2010, whose birthday has not yet passed, to those born in 2017, whose birthday has passed, are eligible.
[Jeon Hae-cheol/Minister of Public Administration and Security: Considering the situation in which safety and effectiveness have been sufficiently verified in overseas countries, and the proportion of those under 11 years old exceeds 15% (total)…
.]
Pediatric Pfizer vaccine, which is one-third the dose of conventional vaccines.
Advance reservations will be made from the 24th, and the inoculation will begin on the 31st at 1,200 designated medical institutions nationwide.
As the interval between Pfizer and Moderna vaccines has been increased to 8 weeks, children aged 5-11 can get their first dose and a second dose 8 weeks later.
Vaccination is recommended for high-risk children with underlying conditions such as chronic lung disease or diabetes.
The rest of the children are left to the parents' discretion, and vaccination is restricted if confirmed before or after the first vaccination.
If you have received the first dose of the vaccine for children, even if you are over 11 years old after your birthday, you will receive the vaccine for children.
The third vaccination was also started between the ages of 12 and 17.
The third dose can be administered 90 days after the second dose, but those with weakened immunity can start after 60 days.
The government will also recognize myocarditis after receiving vaccines from Pfizer or Moderna as an adverse reaction to the vaccine and expand the scope of compensation.